HK Niche Sectors Diverge as MedTech Beats and Biotech Lags in 2026Global Report·Sep 1 at 11:33 AM02788+2.16%01858+1.78%
New Oriental Profits Surge as China Longyuan Power Faces Margin PressuresGlobal Report·Sep 1 at 09:17 AM09901+1.54%06955-2.42%
STOCKS | Youjia Innovation Rises 8.2% As Boan Biotech Hits Record LowCoinLive·Sep 1 at 01:46 AM06955-2.42%02431+3.98%
Shandong Boan Biotech files HKEX next-day return disclosing share buyback at HKD 3.74 eachPUBT·Aug 28 at 11:54 AM06955-2.42%
Shandong Boan Biotech enters RMB 75 million sale-and-leaseback deal with Industrial Bank Financial LeasingPUBT·Aug 27 at 02:34 PM06955-2.42%601166+1.62%
Shandong Boan Biotech swings to FY26 H1 net loss of RMB 83.01 million; revenue drops 40.8% to RMB 233 millionPUBT·Aug 27 at 02:31 PM06955-2.42%
Shandong Boan Biotech says China CDE accepts IND filing for BA2201 bispecific antibodyPUBT·Aug 26 at 11:03 AM06955-2.42%
The Island of Misfit Stocks: Cut the PR, Here is What JD and the AI Hopefuls Are Really DoingGlobal Report·Aug 25 at 09:20 AM89618+3.71%024380.00%
Shandong Boan Biotech completes China Phase Ia trial of BA1302 CD228-targeted ADCPUBT·Aug 14 at 02:17 PM06955-2.42%
Shandong Boan Biotech expects H1 net loss RMB 79 million-RMB 89 millionPUBT·Aug 14 at 02:16 PM06955-2.42%
Shandong Boan files Brazil marketing application for BA9101 aflibercept biosimilar with ANVISAPUBT·Aug 5 at 12:02 PM06955-2.42%
Shandong Boan says China CDE accepts IND filing for BA1203 masked anti-PD-1/IL-2 fusion proteinPUBT·Jul 8 at 04:01 AM06955-2.42%
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy ComboTip Ranks·Jul 2 at 11:38 AM06955-2.42%
